Allogene Therapeutics(ALLO)
搜索文档
Allogene Therapeutics(ALLO) - 2022 Q2 - Earnings Call Transcript
2022-08-10 10:36
Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q2 2022 Earnings Conference Call August 9, 2022 5:00 PM ET Company Participants Christine Cassiano – Chief Communications Officer David Chang – President and Chief Executive Officer Rafael Amado – Executive Vice President-Research and Development and Chief Medical Officer Eric Schmidt – Chief Financial Officer Conference Call Participants Tyler Van Buren – Cowen Salveen Richter – Goldman Sachs Michael Yee – Jefferies Kelsey Goodwin – Guggenheim Ren Benjamin – JMP Se ...
Allogene Therapeutics(ALLO) - 2022 Q1 - Earnings Call Transcript
2022-05-05 10:48
Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q1 2022 Earnings Conference Call May 4, 2022 5:00 PM ET Company Participants Christine Cassiano - Chief Communications Officer David Chang - President and Chief Executive Officer Rafael Amado - EVP of Research and Development and Chief Medical Officer Eric Schmidt - Chief Financial Officer Conference Call Participants Tyler Van Buren - Cowen Cory Kasimov - JP Morgan Salveen Richter - Goldman Sachs John Newman - Canaccord Luca Issi - RBC Capital Kalpit Patel - B. Ril ...
Allogene Therapeutics(ALLO) - 2021 Q4 - Earnings Call Transcript
2022-02-24 12:42
Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q4 2021 Earnings Conference Call February 23, 2022 5:00 PM ET Company Participants Christine Cassiano - Chief Communications Officer David Chang - President & Chief Executive Officer Rafael Amado - Executive Vice President, Research & Development & Chief Medical Officer Alison Moore - Chief Technical Officer Eric Schmidt - Chief Financial Officer Conference Call Participants Michael Yee - Jefferies Salveen Richter - Goldman Sachs Tyler Van Buren - Cowen Mark Breiden ...